4-tert-Butylcalix[5]arene

Catalog No. :
ACMPYX427
CAS No. :
81475-22-1
Molecular Formula :
C55H70O5
Molecular Weight :
811.16

IUPAC Name:15,35,55,75,95-penta-tert-butyl-1,3,5,7,9(1,3)-pentabenzenacyclodecaphane-12,32,52,72,92-pentaol

4-tert-Butylcalix[5]arene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$134.00Login to see priceIn stockInquiry
250mg95%$270.00Login to see priceIn stockInquiry
1g95%$679.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-tert-Butylcalix[5]arene
IUPAC Name15,35,55,75,95-penta-tert-butyl-1,3,5,7,9(1,3)-pentabenzenacyclodecaphane-12,32,52,72,92-pentaol
MDL No.MFCD00210028
Molecular FormulaC55H70O5
Molecular Weight811.16
SMILESOC1=C(CC2=CC(C(C)(C)C)=CC(CC3=CC(C(C)(C)C)=CC(CC4=C(O)C(C5)=CC(C(C)(C)C)=C4)=C3O)=C2O)C=C(C(C)(C)C)C=C1CC6=CC(C(C)(C)C)=CC5=C6O
InChI KeyHTJNUHSOASZVHV-UHFFFAOYSA-N
SynonymAKOS025213645 | 4-tert-Butylcalix[5]arene | 4-tert-Butylcalix(5)arene | FT-0696068 | Penta-tert-butyl(pentahydroxy)calix[5]arene | D88908 | B2221 | DTXSID60369362 | F1170-0408 | CS-0366751 | 5,11,17,23,29-pentatert-butylhexacyclo[25.3.1.13,7.19,13.115,19.
CAS No.81475-22-1
PubChem CID2725100

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACMPYX427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMPYX427 route product structure diagram
    ACMPYX42781475-22-1 In Stock
Inquiry

2. ACMPYX427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMPYX427 route product structure diagram
    ACMPYX42781475-22-1 In Stock
Inquiry

Comments (0)